Cargando…
What Risk Assessments of Genetically Modified Organisms Can Learn from Institutional Analyses of Public Health Risks
The risks of genetically modified organisms (GMOs) are evaluated traditionally by combining hazard identification and exposure estimates to provide decision support for regulatory agencies. We question the utility of the classical risk paradigm and discuss its evolution in GMO risk assessment. First...
Autores principales: | Rajan, S. Ravi, Letourneau, Deborah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502034/ https://www.ncbi.nlm.nih.gov/pubmed/23193357 http://dx.doi.org/10.1155/2012/203093 |
Ejemplares similares
-
Environmental risk assessment of genetically modified organisms /
Publicado: (2004) -
Equivalence Testing
Approaches in Genetically Modified
Organism Risk Assessment
por: van der Voet, Hilko, et al.
Publicado: (2019) -
Publication of clinical trial protocols – what can we learn?
por: Skogvoll, Eirik, et al.
Publicado: (2013) -
Risk assessment and cost-benefit analyses: in the public interest?
por: Wiener, J O
Publicado: (1993) -
Recovering the Original Intentions of Risk Assessment and Management of Genetically Modified Organisms in the European Union
por: Eriksson, Dennis
Publicado: (2018)